Proton therapy is a type of radiation called proton beam radiation therapy it is safer and more effective than conventional radiation therapy for adults with advanced stages cancer. Since, conventional radiation delivers x-rays, or beams of photons, to the tumor and beyond it. This can damage nearby healthy tissues and can cause significant side effects. On the contrary, proton therapy delivers a beam of proton particles that stops at the tumor, making it less likely to damage nearby healthy tissues. Across the globe, experts believe that proton therapy is safer than traditional radiation. However the slight drawback is that there is limited research in proton therapy comparing to the radiation treatments. As per Renub Research, The Global Proton Therapy Market will surpass US$ 77 Billion by 2027.


In this report, we have covered 12 countries proton therapy market and patient numbers. Both the market and patient numbers have been defined from two points Actual and Potential.


Actual Market or Numbers: This is the current Market or Number which is already present.


Potential Market or Numbers: This is the Market or Numbers which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year


Worldwide Proton Therapy Market Size was US$ 68.1 Billion in 2021

The global proton therapy market will be growing rapidly due to a surging number of proton therapy centers across the world. And at the same time, many number of proton therapy centers are in the construction and in planning phases across the countries. In addition the other growth factors driving the global proton therapy market are advancement in the technology, surging prevalence of cancer patients worldwide. However to some extent, the factors such as huge investment required in this therapy as well as operations are the challenges which may hinder its market growth.


United States has the Largest Number of Proton Therapy Centers Globally

United States is the hub of proton therapy Industry having highest number of proton therapy centers globally. The United Kingdom is expected to launch advanced multi-room proton therapy centers owned by the NHS and Private Players in future. Similarly, the emerging countries are also escalating their demand for proton therapy in their regions as some cancer and cancer-related cases have been surging and will surely boost the growth of this market during the forecast period. As per our analysis, Global Proton therapy will grow at a CAGR of 2.07% during 2021-2027.


Some Facts on Worldwide Proton Therapy Market

According to the American Cancer Society, about 1.8 million new cancer cases are diagnosed and around 606,520 cancer deaths happened in the United States in the year 2020.
Europe is also a big market for proton therapy due to growing use of tobacco.
According to Eurostat, 1 in 4 EU citizens over 15 years old (24%) is a tobacco smoker.
The World Health Organization stated that nearly 70% deaths due to cancer occur in low and middle income countries like Asia Pacific and this region country is expected to enlarge at a higher growth rate because of the growing awareness among people, large target population, and increase in health care expenditure.


COVID-19 Impact on Proton Therapy Industry

Despite the outbreak of COVID-19 around the world, the proton therapy market has grown at a constant rate. Proton therapy radiation therapy was stopped for a brief round of period, but it was resumed again for patients. To take care of the regular patient and radiation therapies patients, in the United States many processes has been finalized to help the patients with therapies. As such many implementation and algorithms have been carried out during the period to safeguard the radiation patients from COVID-19. We expect the post-pandemic recovery for the global proton therapy industry would surge during the forecast period.


Renub Research latest report “Proton Therapy Market, Global Forecast By Countries (United States, United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden, Poland, Japan, Korea, China), Company (IBA Proton Therapy, Varian Medical Systems, Elekta)” provides a detailed analysis of Global Neonatal Intensive Care Industry.


Proton Therapy Market & Patient Numbers breakup of 12 Countries

1. United States
2. United Kingdom
3. Switzerland
4. Russia
5. Germany
6. France
7. Italy
8. Sweden
9. Poland
10. Japan
11. Korea
12. China


All companies have been covered from 3 viewpoints

  • Overviews
  • Recent Developments
  • Sales Analysis




Company

1. IBA Proton Therapy
2. Varian Medical Systems
3. Elekta